Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Revolutionary Danish cancer app marks a milestone in digital healthcare
, /in E-News /by panglobalDenmark’s healthcare system marked a significant milestone with the national implementation of ‘Kræftværket’ (The Cancer Forge). This pioneering digital health solution, designed for young cancer patients, is a collaboration between Daman, young cancer patients, and healthcare professionals. It aims to alleviate loneliness and enhance disease coping. The solution is to be implemented across all five […]
IHF and PAHO/WHO collaborate to strengthen hospital management in the Americas
, /in E-News /by panglobalThe International Hospital Federation (IHF) and the Pan American Health Organization, Regional Office of the World Health Organization (PAHO/WHO) have entered into a technical cooperation agreement on hospital management transformation.
Doctolib acquires Siilo, rebrands and brings its healthcare expertise to the Benelux
, /in E-News /by panglobalSiilo www.siilo.com , a leading medical messaging platform with over 550,000 users, is now globally rebranding to Doctolib Siilo, including the Netherlands and Belgium. This represents the successful integration of Siilo into Doctolib Siilo (Doctolib announced the acquisition of Siilo earlier in 2023). The rebranding also signals a future where Siilo benefits from the innovation […]
Aston University ARCHA programme wins £400,000 funding for new dementia research
, /in E-News /by panglobalThe Aston Research Centre for Health in Ageing (ARCHA) at Aston University has received £400,000 in funding to recruit four PhD students for a dementia research programme. Four students will work on the Aston Brain Health Cohort Study (ABaHCoS), which will research tests for the early detection of dementia before symptoms become apparent. Two of […]
Oncodesign Services, a leading European CRO in preclinical drug discovery acquires ZoBio, a CRO specialized in small molecule drug discovery
, /in E-News /by panglobalOncodesign Services (ODS), a leading Contract Research Organization specialized in drug discovery and preclinical services, announces its international expansion through the acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery.
Risk of dementia 80% higher after stroke
, /in Featured Articles /by panglobalHaving a stroke may significantly increase the risk of developing dementia, according to preliminary research that was due to be presented at the American Stroke Association’s International Stroke Conference 2024, in Phoenix, Feb. 7-9.
Novel molecular assay holds promise for early detection of Parkinson’s disease
, /in Featured Articles /by panglobalA new method for detecting and quantifying minute amounts of a biomarker of Parkinson’s and related diseases could open up opportunity for much-needed early pre-symptomatic diagnosis. Haley Bridger, Brigham and Women’s Hospital communications, and Benjamin Boettner, Wyss Institute communications, report.
Researchers call for a neurological disease paradigm shift
, /in Featured Articles /by panglobalBE-LIGHT project to develop new photonics and AI tools for diagnosis of several diseases
, /in Featured Articles /by panglobalA new European research project called BE-LIGHT has received €2.5 million in funding from the EU’s Horizon Europe programme to develop new photonics and AI tools for the early detection and treatment of ocular, cardiovascular and neurodegenerative diseases. The project is coordinated by the Centre for Sensors, Instruments and Systems Development (CD6) at Universitat Politècnica […]
Novel PET tracer enhances lesion detection in medullary thyroid cancer, offers potential for targeted therapy
, /in Featured Articles /by panglobalA newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January issue of The Journal of Nuclear Medicine [1]. The results of the studies indicate that the PET imaging agent may be a promising theranostic candidate […]